PET imaging of amyloid with Florbetapir F 18 and PET imaging of dopamine degeneration with (18)F-AV-133 (florbenazine) in patients with Alzheimer’s disease and Lewy body disorders

BACKGROUND: Biomarkers based on the underlying pathology of Alzheimer’s disease (AD) and Dementia with Lewy Bodies (DLB) have the potential to improve diagnosis and understanding of the substrate for cognitive impairment in these disorders. The objective of this study was to compare the patterns of...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Siderowf, Andrew, Pontecorvo, Michael J, Shill, Holly A, Mintun, Mark A, Arora, Anupa, Joshi, Abhinay D, Lu, Ming, Adler, Charles H, Galasko, Douglas, Liebsack, Carolyn, Skovronsky, Daniel M, Sabbagh, Marwan N
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2014
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4027995/
https://ncbi.nlm.nih.gov/pubmed/24716655
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2377-14-79
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires